John Evans is Chief Executive Officer of Beam Therapeutics Inc. (BEAM). The company reported total compensation of $5,818,525 for fiscal year 2025.
| Salary | $755,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,513,575 |
| Option awards | $2,876,754 |
| Non-equity incentive plan | $662,513 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $10,684 |
| Total | $5,818,525 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Beam Therapeutics Inc. filed April 17, 2026, accession 0001193125-26-161512.
| Peer-group chief executive median | $6,406,526 |
|---|---|
| Difference from that median | $-588,001 |
| Percentile within the disclosed peer group | 50th |
| Peers with a disclosed figure | 16 |
Medians and percentiles are computed across the peer group Beam Therapeutics Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| John Evans this page | Chief Executive Officer | $5,818,525 |
| Giuseppe Ciaramella | President | $3,160,279 |
| Amy Simon | Chief Medical Officer | $2,802,044 |
| Christine Bellon | Chief Legal Officer and Secretary | $1,967,177 |
| Sravan Emany | Chief Financial Officer | $1,296,528 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Beam Therapeutics Inc. compensation brief.
John Evans's compensation sits inside Beam Therapeutics Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.